Nervous Dyspepsia Research Articles

Sonochemical Synthesis and Characterization of Bismuth Aluminate Nanocrystals

Bismuth aluminate is a kind of antacid medicine which is used to treat peptic ulceration and nervous dyspepsia. In our experiment, a simple solution strategy via supersonic method for the synthesis of spherical bismuth aluminate nanoparticles at room temperature is presented. During the procedure, bismuth aluminate was directly precipitated from the solution in the ultrasonic syringe under strong alkaline condition and its chemical empirical formula was defined by inductively coupled plasma(ICP) analysis, element analyzer(EA) and analysis analysis. XRD, FTIR and TEM, have been employed to characterize the obtained nanocrystals. Preparative parameters, such as the pH value, drying temperature and the sonication time were optimized to obtain Bi2(Al2O4)3•10H2O nanomaterials with considerable yield, uniform shape and narrow size distributions.

German publications on anorexia nervosa in the nineteenth century

After its first description in 1873, anorexia nervosa seems not to have attracted much attention in German-speaking countries. Compared to French and English literature, German publications on the subject were rather scarce in the nineteenth century. This article gives an overview of those writings and an explanation of the lack of interest on the part of German-speaking physicians. Apparently, anorexia nervosa did not appeal to them as a nosological entity distinct from the popular diagnosis of “nervous dyspepsia”.

Psychosocial and childhood factors in essential dyspepsia. A case-control study.

A subgroup of patients with endoscopically diagnosed non-ulcer dyspepsia have no definite cause for their symptoms, termed essential dyspepsia; such patients have been considered to have 'nervous dyspepsia'. To determine whether social and environmental factors are of importance, both in childhood (before the onset of symptoms) and in adult life, 109 patients with essential dyspepsia and 109 randomly selected dyspepsia-free community controls (matched for age, sex, and one measure of social grade-suburb of residence) were studied. Socioeconomic status, marital status, childhood environment, family structure, and migration were measured. An increased risk of essential dyspepsia was associated with one aspect of social status incongruity; compared with controls, patients had a lower occupational status than their place of residence indicated (OR = 2.3; 95% CI, 1.5-3.5). There was a trend for patients to report an unhappy childhood (OR = 2.4; 95% CI, 0.9-6.7). Being unmarried, undergoing parental separation during childhood, the patient's age at parental separation, the number of siblings, birth order, country of birth, and years of residence were not significantly associated with essential dyspepsia. The importance of psychosocial and childhood factors in essential dyspepsia is probably small.

Association of anxiety, neuroticism, and depression with dyspepsia of unknown cause

Abstract Non-ulcer dyspepsia, aJso termed "nervous dyspepsia," is a heterogeneous syndrome: ulcerlike symptoms can occur with the irritable bowel syndrome, gastroesophageal reflux, and other disorders. In addition, there is a significant subgroup of nonulcer dyspepsia sufferers who have no disorder associated with, and no known cause for, their dyspepsia, and the dyspepsia in this subgroup is given the provisional name of "essential dyspepsia." The aim of this study was to assess if psychological factors are associated with patients who present with essential dyspepsia. Psychometric testing was carried out on 76 essential dyspepsia patients (including 18 patients with gastroduodenitis), 76 randomly selected dyspepsia-free community controls (matched for age, sex, and social class), and 66 duodenal ulcer controls. Essential dyspepsia patients were retested a mean of 3.6 mo later. Using stepwise regression analysis, the initial scores of essential dyspepsia and duodenal ulcer subjects showed them to be more neurotic, anxious, and depressed than community controls; these abnormalities persisted in essential dyspepsia patients on retesting and were not affected by the symptom status. It is concluded that essential dyspepsia patients who present for investigation with symptoms are more likely to be persistently neurotic, anxious, and depressed than dyspepsia-free controls, and this is unrelated to the presence of symptoms, but the association may not be of major clinical significance, as the numerical differences observed between groups were small and the correlation coefficients were low.

Association of anxiety, neuroticism, and depression with dyspepsia of unknown cause: A case-control study

Non-ulcer dyspepsia, aJso termed “nervous dyspepsia,” is a heterogeneous syndrome: ulcerlike symptoms can occur with the irritable bowel syndrome, gastroesophageal reflux, and other disorders. In addition, there is a significant subgroup of nonulcer dyspepsia sufferers who have no disorder associated with, and no known cause for, their dyspepsia, and the dyspepsia in this subgroup is given the provisional name of “essential dyspepsia.” The aim of this study was to assess if psychological factors are associated with patients who present with essential dyspepsia. Psychometric testing was carried out on 76 essential dyspepsia patients (including 18 patients with gastroduodenitis), 76 randomly selected dyspepsia-free community controls (matched for age, sex, and social class), and 66 duodenal ulcer controls. Essential dyspepsia patients were retested a mean of 3.6 mo later. Using stepwise regression analysis, the initial scores of essential dyspepsia and duodenal ulcer subjects showed them to be more neurotic, anxious, and depressed than community controls; these abnormalities persisted in essential dyspepsia patients on retesting and were not affected by the symptom status. It is concluded that essential dyspepsia patients who present for investigation with symptoms are more likely to be persistently neurotic, anxious, and depressed than dyspepsia-free controls, and this is unrelated to the presence of symptoms, but the association may not be of major clinical significance, as the numerical differences observed between groups were small and the correlation coefficients were low.

Correction

Medical Journal of AustraliaVolume 143, Issue 4 p. 176-176 CorrectionFree Access Correction This article corrects the following: Nervous dyspepsia John R. Graham FRACP, Barry J. Marshall FRACP, Volume 142Issue 13Medical Journal of Australia pages: 704-704 First Published online: June 1, 1985 First published: 01 August 1985 https://doi.org/10.5694/j.1326-5377.1985.tb122904.xAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume143, Issue4August 1985Pages 176-176 RelatedInformation

Further Experience with Bismuth Aluminate in Peptic Ulceration and Nervous Dyspepsia

Further Experience with Bismuth Aluminate in Peptic Ulceration and Nervous Dyspepsia

Librium and valium

Chlordiazepoxide (Librium - Roche) was first marketed in 1960, five years after meprobamate. It is now more widely prescribed in the United States than any other “tranquilliser” for the treatment of common anxiety and tension states. The manufacturers recommend it for the treatment of a variety of emotional symptoms, acute and chronic alcoholism and some physical complaints arising from emotional disturbances. Diazepam (Valium - Roche) is a newer drug chemically related to chlordiazepoxide and its advertised indications are similar to those suggested for Librium. Librium is also an ingredient (with clidinium) of Libraxin (Roche) for the treatment of nervous dyspepsia, and Valium (with pentaerythritol tetranitrate) of Pentrium for the treatment of angina. Valium is said to differ “quantitatively” and “qualitatively” from Librium, than which it is reputedly five times more potent when milligram dosages are compared. However, this constitutes no advantage if the ratio of unwanted to therapeutic effects is unchanged at the lower dosage. There is in fact little evidence of any qualitative pharmacological differences, but some patients prefer Valium to Librium for the relief of their anxiety. On the other hand, many psychiatrists would agree that the attempt to remove the symptom of anxiety with any drug is in the long run bound to be “anti-therapeutic”.

THE PERNICIOUS TYPE OF NERVOUS DYSPEPSIA

Excerpt That there is such a nosological entity as nervous dyspepsia is generally admitted. It constitutes a large proportion of the practitioner's clinical office material. The real difficulty beg...

Diagnosis and Treatment of Nervous Dyspepsia

Diagnosis and Treatment of Nervous Dyspepsia

Oral Administration of Metaphen in the Treatment of Gastric and Duodenal Ulcers

Article1 January 1933Oral Administration of Metaphen in the Treatment of Gastric and Duodenal UlcersCLARENCE MORTON TRIPPE, A.M., M.D., F.A.C.P.CLARENCE MORTON TRIPPE, A.M., M.D., F.A.C.P.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-6-7-901 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptThe opinion is at present generally held that many patients with ulcer belong to the spasmophilic-vasoneurotic type, and therefore antispasmodic drugs, such as atropine and belladonna, in conjunction with the Sippy diet, are used in the treatment of ulcers and nervous dyspepsia. However, it is the opinion of the author (and also that of many other neurologists) that more attention must be paid to direct treatment of the stomach and the intestines, and that one should not rely exclusively on the above and on general methods of psychotherapy and physiotherapy, as, for instance, drug sedatives and stimulants. In the direct...References1 AARON CD: Diseases of the digestive organs with special reference to their diagnosis and treatment, 1918, Lea & Febiger, Philadelphia, 448. Google Scholar2 RAIZISSSEVERAC GWM: A new organic mercury compound with powerful germicidal properties, Jr. Lab. and Clin. Med., 1923, ix, 71-80. Google Scholar3 RAIZISSSEVERAC GWM: Metaphen (4-nitro-3, 5-biacetoxymercuri-2-cresol) and its bactericidal properties, Jr. Infect. Dis., 1927, xl, 447-452. CrossrefGoogle Scholar4 BIRKHAUG KE: Metaphen (4-nitro-3, 5-biacetoxymercuri-2-cresol); comparative study of commonly used disinfectants and antiseptics; histologic changes produced by intravenous administration of metaphen in rabbits, Jr. Am. Med. Assoc., 1930, xcv, 917-923. CrossrefGoogle Scholar5 HIRSCHFELDERWRIGHT ADHN: Studies on colloid chemistry of antisepsis and chemotherapy; ultramicroscopic examination of neoarsphenamine and of certain antiseptics, and their effects upon protein solutions, Jr. Pharmacol. and Exper. Therap., 1930, xxxix, 13-27. Google Scholar6 YORK DA: First aid and after treatment of minor injuries, Texas State Jr. Med., 1927, xxii, 709-710. Google Scholar7 THOREK M: The etiology, prevention and treatment of post-operative wound infections, Ill. Med. Jr., 1926, 1, 477-483. Google Scholar8 BLEDSOE RE: Metaphen locally and intravenously, Jr. Chemotherapy, 1928, v, no. I, 37. Google Scholar9 FISKE S: Metaphen in streptococcic lymphangitis and adenitis (a case report), Clin. Med and Surg., 1927, xxxiv, 378-379. Google Scholar10 SPOTTS SD: Metaphen in treatment of peritonitis, Jr. Chemotherapy, 1927, iv, no. 2., 48-50. Google Scholar11 FISHER R: Ruptured appendix and peritonitis treated with metaphen (a case report), Clin. Med. and Surg., 1927, xxxiv, 857-858. Google Scholar12 JAMES F: The etiology and treatment of Vincent's angina, Jr. Chemotherapy, 1929, vi, no. 1, 4-8, and no. 3, 9. Google Scholar13 SYMON WG: Metaphen in the treatment of Vincent's angina, Clin. Med. and Surg., 1931, xxxviii, 825-826. Google Scholar14 BROWN IC: Metaphen in the prevention and treatment of colds, Clin. Med., 1925, xxxii, 181. Google Scholar15 SULLIVAN EC: The treatment and prevention of colds with metaphen, Clin. Med., 1925, xxxii, 150-151. Google Scholar16 FENTON RA: Dyestuff antiseptics in rhinology, Ann. Otol., Rhin. and Laryngol., 1925, xxxiv, 884-886. Google Scholar17 GORMAN JR: Non-operative treatment of chronic otitis media suppurativa, Virginia Med. Monthly, 1926, liii, 378-382. Google Scholar18 DUBOIS LC: Acute prostatitis—a new conception of its etiology and treatment, Clin. Med. and Surg., 1928, xxxv, 331-332. Google Scholar19 BERNSTINE JB: Metaphen in the treatment of puerperal septicemia and other blood stream infections, Am. Jr. Obst. and Gynec., 1929, xviii, 220-229. CrossrefGoogle Scholar20 ROSENOW EC: The production of ulcer of the stomach by injection of streptococci, Jr. Am. Med. Assoc., 1913, lxi, 1947-1950. CrossrefGoogle Scholar21 ROSENOW EC: Relation of and the lesion produced by various forms of streptococci with special reference to arthritis, Jr. Am. Med. Assoc., 1913, lxi, 2007. Google Scholar22 ROSENOW EC: The causation of gastric and duodenal ulcers, by streptococci, Jr. Infect. Dis., 1916, xix, 333-362. CrossrefGoogle Scholar23 ROSENOW EC, Etiology of spontaneous ulcer of stomach in domestic animals, Jr. Infect. Dis., 1923, xxxii, 384-399. CrossrefGoogle Scholar24 CELLERTHALHIMER HLW: Bacteriological and experimental studies on gastric ulcer, Jr. Exper. Med., 1916, xxiii, 791-812. CrossrefGoogle Scholar25 DUVAL P: Note sur la rôle de l'infection dans l'évolution des ulcères gastro-duodenaux et sur les indication thérapeutiques qui peuvent en résulter, l'Acad. de med., 1924, xcii, 1257-1259. Google Scholar26 DUVALROUXMOUTIER PJCF: Rôle de l'infection dans l'évolution des ulcères gastro-duodenaux; indications thérapeutiques, Presse méd., 1925, xxxiii 3. Google Scholar27 ASKANAZY M: Über Bau und Entstehung des chron. Magengeschwürs, sowie Soorpilzbefund in ihm, Virchows Arch. f. path. Anat., 1921, ccxxxiv, 111-178. CrossrefGoogle Scholar28 SMITHIES F: Observations upon the nature, diagnosis and clinical management of gastric ulcers with suggestions for a rational regimen of treatment, Am. Jr. Med. Sci., 1923, clxvi, 781-801. CrossrefGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Asbury Park, New Jersey PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByCertain newer methods of treating peptic ulcer 1 January 1933Volume 6, Issue 7Page: 901-912KeywordsAtropineDietDrug psychotherapyDrugsDuodenal ulcersGastric ulcersOral administrationPhysiotherapySedativesStomach Issue Published: 1 January 1933 PDF DownloadLoading ...

CONCLUSIONS BASED ON A STUDY OF FOUR THOUSAND CASES OF GOITER*

The material on which the conclusions in this paper are based consists of four thousand surgical and non-surgical cases of goiter which I have observed during the past five years at the Jackson Clinic and as a Fellow in Goiter Surgery at the Mayo Clinic. Although these observations are for the most part not new, they are culled from a great mass of facts and for the first time formulated in brief statements. Advanced cases of exophthalmic goiter are at times treated as endocarditis by heart specialists, as nervous dyspepsia by gastroenterologists, and as neurosis by neurologists. Little discrimination is made between cases of adenoma of the thyroid with hyperthyroidism and exophthalmic goiter. They are all too generally called “toxic goiter.” The study of goiter is complex, and much confusion exists over the diagnosis and treatment of the various forms.

Lehrbuch der Magen- und Darmkrankheiten.

The third edition of Dr. Zweigs' treatise on diseases of the stomach and intestines contains, as new features, the recasting of the article on methods of examination and treatment, and a rewriting of the chapters on ulcer, and putrefactive and fermentative diarrheas. The author takes a rational view of his subject, and describes it clearly and simply. Subjects like chronic gastritis, which is, after all, uncommon, and nervous dyspepsia seem to be accorded more space than their importance would warrant. This, however, is a question. The writer speaks of disinfection of the bowel with boric acid lavage and salicylic acid; the value of this proceedure will probably not receive much proof. It would be interesting to know just how frequently a dorsal pressure point in peptic ulcer occurs in the experience of American physicians, and compare it with the frequency in the experience of German authors; Zweig finds it fairly

Entero-Colite: Estomac et Systeme Nerveun.

The author sustains the proposition that the condition commonly known as membranous colitis or colitis mucosa is closely connected with nervous dyspepsia and with enteroptosis. He regards the intestinal condition as directly dependent on the failure of the stomach to perform its functions, and therefore directs his therapeutic measures to the cure of the fundamental affection. He attributes the influence of the in producing the pathologic condition of the intestine the irritation of the solar plexus which is set up by abnormal gastric conditions, is transmitted to the intestinal plexus, and thus causes the intestinal symptoms. The chapter therapeutics includes a consideration of the dietetic and physical measures suitable to the cure of the dyspepsia as well as to the medicinal treatment. The importance of psychotherapy is recognized. The treatment appears to be in accordthese with the methods usually followed in the treatment of these affections. The emphasis which the author

CHILDBIRTH AFTER APPARENT MENOPAUSE

C. H., a well preserved and healthy looking woman, aged 50 years, always menstruated regularly and never had any genital troubles till 15 years ago. At that time she gave birth to twins, making the number of children seven in all. About a year later menstruation returned but with considerable irregularity; and in another year it ceased altogether. Two years ago, 11 years after the cessation of menstruation, she began to feel out of sorts; she lost her appetite, had nausea and felt weak. She was examined and treated by several physicians, including myself, at various times, but her true condition was not diagnosed and she remained unrelieved. One doctor told her that she had a growth and an operation would be necessary to remove it. The others treated her for gastritis, nervous dyspepsia, etc. She began to worry over her troubles and became much emaciated, anemic and nervous. One

Über Nervöse Dyspepsie

ALTHOUGH this work of 100 pages claims to be a collection of psychiatric researches from the Medizinische Klinik at Heidelberg, it is of the nature rather of a critical digest than an attempt to add much to our knowledge of the subject with which it deals. The researches consist of careful investigation of twelve patients suffering from nervous dyspepsia, including the chemical analysis of the gastric contents after the administration of test-breakfasts. The cases are carefully recorded.

EXPERIMENTAL BASIS OF THE DIETETIC AND MEDICINAL TREATMENT OF HYPERACIDITY AND GASTRITIS.

Boas, who first used the finding of fragments of mucosa in the vomited matter and gastric wash water for diagnostic purposes, attributed great importance to this way of finding out the real state of the mucosa. He held that, in certain conditions of suppressed secretion, the differential diagnosis between a possible neurosis and a genuine gastritis with a glandular atrophy was only possible by examination of such pieces of mucosa. Rosenheim, Boas and Julius Friedenwald,<i>Med. News</i>, June 22, 1895, emphasize the value of qualitative and quantitative testing of rennet zymogen to differentiate between chronic gastritis with glandular atrophy and carcinoma on the one hand, and nervous dyspepsia and secondary gastritis on the other. However, Ewald and also Einhorn have asserted that absolute deficiency of rennet zymogen is not pathognostic for atrophy, therefore it would indeed seem as if a certain diagnosis could only be made by a small piece